Literature DB >> 24148194

Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity.

B Nellemann1, M H Vendelbo, T S Nielsen, A M Bak, M Høgild, S B Pedersen, R S Biensø, H Pilegaard, N Møller, N Jessen, J O L Jørgensen.   

Abstract

AIM: Insulin resistance induced by growth hormone (GH) is linked to promotion of lipolysis by unknown mechanisms. We hypothesized that suppression of the activity of pyruvate dehydrogenase in the active form (PDHa) underlies GH-induced insulin resistance similar to what is observed during fasting.
METHODS: Eight healthy male subjects were studied four times in a randomized, single-blinded parallel design: Control, GH, Fasting (36 h) and GH + Fasting. GH (30 ng × kg(-1) × min(-1)) or saline was infused throughout the metabolic study day. Substrate metabolism and insulin sensitivity were assessed by indirect calorimetry and isotopically determined rates of glucose turnover before and after a hyperinsulinemic euglycemic clamp. PDHa activity, PDH-E1α phosphorylation, PDK4 expression and activation of insulin signalling proteins were assessed in skeletal muscle.
RESULTS: Both fasting and GH promoted lipolysis, which was associated with ≈50% reduction in insulin sensitivity compared with the control day. PDHa activity was significantly reduced by GH as well as fasting. This was associated with increased inhibitory PDH-E1α phosphorylation on site 1 (Ser(293)) and 2 (Ser(300)) and up-regulation of PDK4 mRNA, while canonical insulin signalling to glucose transport was unaffected.
CONCLUSION: Competition between intermediates of glucose and fatty acids seems to play a causal role in insulin resistance induced by GH in human subjects.
© 2013 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  fasting; growth hormone; pyruvate dehydrogenase; substrate oxidation

Mesh:

Substances:

Year:  2013        PMID: 24148194     DOI: 10.1111/apha.12183

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  17 in total

1.  Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity.

Authors:  Yash Chhabra; Caroline N Nelson; Monika Plescher; Johanna L Barclay; Aaron G Smith; Sof Andrikopoulos; Salvatore Mangiafico; David J Waxman; Andrew J Brooks; Michael J Waters
Journal:  FASEB J       Date:  2019-02-19       Impact factor: 5.191

2.  Growth hormone acts along the PPARγ-FSP27 axis to stimulate lipolysis in human adipocytes.

Authors:  Vishva M Sharma; Esben Thyssen Vestergaard; Niels Jessen; Peter Kolind-Thomsen; Birgitte Nellemann; Thomas S Nielsen; Mikkel Holm Vendelbo; Niels Møller; Rita Sharma; Kevin Y Lee; John J Kopchick; Jens Otto Lunde Jørgensen; Vishwajeet Puri
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-10-16       Impact factor: 4.310

Review 3.  Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Authors:  Adi J Klil-Drori; Laurent Azoulay; Michael N Pollak
Journal:  Nat Rev Clin Oncol       Date:  2016-08-09       Impact factor: 66.675

Review 4.  Effect of growth hormone on insulin signaling.

Authors:  Rita Sharma; John J Kopchick; Vishwajeet Puri; Vishva M Sharma
Journal:  Mol Cell Endocrinol       Date:  2020-09-20       Impact factor: 4.102

Review 5.  Adipose tissue lipolysis and remodeling during the transition period of dairy cows.

Authors:  G Andres Contreras; Clarissa Strieder-Barboza; William Raphael
Journal:  J Anim Sci Biotechnol       Date:  2017-05-05

6.  Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells.

Authors:  Andreas David Zimmer; Geoffroy Walbrecq; Ines Kozar; Iris Behrmann; Claude Haan
Journal:  Hypoxia (Auckl)       Date:  2016-08-16

7.  Regulation of hepatic pyruvate dehydrogenase phosphorylation in offspring glucose intolerance induced by intrauterine hyperglycemia.

Authors:  Yong Zhang; Ying Zhang; Guo-Lian Ding; Xin-Mei Liu; Jianping Ye; Jian-Zhong Sheng; Jianxia Fan; He-Feng Huang
Journal:  Oncotarget       Date:  2017-02-28

Review 8.  Targeting growth hormone function: strategies and therapeutic applications.

Authors:  Man Lu; Jack U Flanagan; Ries J Langley; Michael P Hay; Jo K Perry
Journal:  Signal Transduct Target Ther       Date:  2019-02-08

9.  The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility.

Authors:  Shuai Zhang; Matthew W Hulver; Ryan P McMillan; Mark A Cline; Elizabeth R Gilbert
Journal:  Nutr Metab (Lond)       Date:  2014-02-12       Impact factor: 4.169

Review 10.  The role of pyruvate dehydrogenase kinase in diabetes and obesity.

Authors:  In-Kyu Lee
Journal:  Diabetes Metab J       Date:  2014-06       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.